Silicon Biochip Microcavities for Sensitive RSV Nucleic Acid Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Respiratory Syncytial Virus (RSV) infection in children are expensive, have low sensitivity and specificity, and lack cost-effectiveness, necessitating a more robust and sensitive detection technology.
Innovation Solution
A silicon-based biochip with microcavities is used for detecting target nucleic acid sequences, where nucleic acid is immobilized on the chip in a sol-gel composition, and a detector nucleic acid with a complementary sequence, labeled with a fluorescent molecule, is employed to detect hybridization, enabling sensitive and specific RSV detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic methods are used for RSV detection, then the diagnostic process is simple and inexpensive, but the sensitivity and specificity are low
Solution Approach 1:
The diagnostic method is segmented into distinct functional modules: nucleic acid immobilization on silicon microcavities, hybridization with fluorescently labeled probes, and optical detection. This modular approach enables high sensitivity detection while maintaining operational simplicity through standardized protocols for each module.
Solution Approach 2:
Silicon microcavities with porous structures are used to immobilize nucleic acid targets, providing high surface area for binding while enabling selective penetration of detection reagents. The porous architecture enhances detection sensitivity through increased interaction surfaces without complicating the overall device structure.
2Measurement precision
If conventional diagnostic methods are used for RSV detection, then the cost is low, but the selectivity and sensitivity are insufficient
Solution Approach 1:
The detection system utilizes changes in optical parameters (fluorescence intensity, wavelength shifts) upon hybridization to achieve high specificity. By monitoring these parameter changes rather than relying on complex chemical assays, the method maintains cost-effectiveness while dramatically improving detection precision and selectivity.
Solution Approach 2:
Fluorescently labeled nucleic acid probes serve as intermediaries between the immobilized target DNA and the detection system. These probes provide specific recognition through complementary base pairing while the fluorescent label enables sensitive optical detection, achieving high specificity without requiring complex manufacturing processes.
3Measurement precision
If fluorescent labeling is used for detection, then the sensitivity and real-time monitoring capability are improved, but the cost and complexity of reagent preparation increase
Solution Approach 1:
The fluorescent label, probe sequence, and detection functionality are merged into a single integrated reagent molecule. This combination eliminates the need for separate labeling steps and reduces reagent preparation complexity while maintaining high sensitivity and enabling real-time monitoring through the fluorescent signal.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides high sensitivity, selectivity, and cost-effectiveness for RSV detection, outperforming existing technologies in terms of time, selectivity, and sensitivity, making it a more efficient diagnostic tool.
Implementation Method 1
a detector nucleic acid, such as an oligonucleotide probe, having a sequence substantially complementary to the target nucleic acid sequence can be used to detect the immobilized nucleic acid on the silicon. If the nucleic acid used for detection hybridizes with a nucleotide sequence of a nucleic acid immobilized on the silicon, the hybridized sequences can be detected by direct or indirect means
Data Source
AI summary
The subject invention concerns materials and methods for detecting nucleic acid sequences. One aspect of the invention concerns a silicon-based “biochip” comprising nucleic acid immobilized thereon. In one embodiment, the silicon comprises microcavities. The nucleic acid to be assayed for the presence of one or more target nucleic acid sequences is immobilized on the silicon. A nucleic acid, such as an oligonucleotide probe, having a sequence substantially complementary to the target nucleic acid sequence can be used to detect the immobilized nucleic acid on the silicon. If the nucleic acid used for detection hybridizes with a target nucleic acid sequence, the hybridized sequences can be detected directly or indirectly. In an exemplified embodiment, the oligonucleotide probe can be labeled with a detectable label, for example, a fluorescent molecule. The subject invention also concerns methods for detecting a target nucleic acid using a silicon-based biochip of the invention.